Cellectar Biosciences, Inc. Deferred Tax Liabilities, Property, Plant and Equipment
Cellectar Biosciences, Inc. (CLRB) had Deferred Tax Liabilities, Property, Plant and Equipment of $98.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-03-04
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $98.00K.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $123.00K; Deferred Tax Liabilities, Property, Plant and Equipment as first filed $123.19K.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $156.63K.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $157.50K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment | Deferred Tax Liabilities, Property, Plant and Equipment as first filed |
|---|---|---|
| 2025-12-31 | $98.00K 10-K · filed 2026-03-04 | |
| 2024-12-31 | $123.00K 10-K · filed 2026-03-04 | $123.19K 10-K · filed 2025-03-13 |
| 2023-12-31 | $156.63K 10-K · filed 2025-03-13 | |
| 2022-12-31 | $157.50K 10-K/A · filed 2024-10-29 | |
| 2021-12-31 | $59.96K 10-K · filed 2023-03-09 | |
| 2020-12-31 | $110.70K 10-K · filed 2022-03-21 | |
| 2019-12-31 | $153.93K 10-K · filed 2021-03-02 | |
| 2018-12-31 | $89.13K 10-K · filed 2020-03-09 | |
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 | |
| 2016-12-31 | $150.20K 10-K · filed 2018-03-21 | |
| 2015-12-31 | $171.60K 10-K · filed 2017-03-15 | |
| 2014-12-31 | $245.78K 10-K/A · filed 2016-10-20 | |
| 2013-12-31 | $257.31K 10-K · filed 2015-05-20 | |
| 2012-12-31 | $271.05K 10-K · filed 2014-03-19 | -$271.05K 10-K · filed 2013-03-28 |
| 2011-12-31 | -$346.87K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |